Skip to main content
Clinical Trials/RBR-6mkndk
RBR-6mkndk
Not yet recruiting
Phase 1

Evaluation of the analgesic effect of Pregabalin for arthralgia after Chikungunya

Rodrigo Souza Rodrigues0 sitesNovember 11, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Joint pain
Sponsor
Rodrigo Souza Rodrigues
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Rodrigo Souza Rodrigues

Eligibility Criteria

Inclusion Criteria

  • 35 participants will be included aged 18 to 100 years old; Both sexes; With chronic illness (more than 3 months); Individuals with arthralgia after chikungunya, previously diagnosed with sorology positive for CHIK; Individuals with pain upper than 4

Exclusion Criteria

  • Non\-inclusion criteria patient with sorologies for CHIK with negative IGG and positive IGM; FR (rheumatoid factor) and FAN (antinuclear factor) positive in high values; Cognitive dysfunction (unable to understand the explanations); Psychiatric illness; Drug user; Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials